publicaciones

Título Añoorden ascendente
Cationic poly(ester amide) dendrimers: alluring materials for biomedical applications. 2018
The effect of PEGytaled Hollow Gold Nanoparticles on Stem Cell Migration Potential Application in Tissue Regeneration. 2017
DNA Transfection to Mesenchymal Stem Cells Using a Novel Type of Pseudodendrimer Based on 2,2-Bis(hydroxymethyl)propionic Acid. 2017
Polymer functionalized gold nanoparticles as non-viral gene delivery reagents. Journal of Gene Medicine. 2017
Comparative study on pluripotency and migratory potentials of different MSCs for cell therapies 2016
Selective Delivery of Photothermal Nanoparticles to Tumors Using Mesenchymal Stem Cells as Trojan-Horses. 2016
.Placental MSCs as vehicles for the endogenous Na/I symporter (hNIS): a new theragnostic strategy 2016
New Ionic bis-MPA and PAMAM Dendrimers: A Study of Their Biocompatibility and DNA-Complexation. 2015
Calcium Homeostasis in Myogenic Differentiation Factor 1 (MyoD)-Transformed, Virally-Transduced, Skin-Derived Equine Myotubes. 2014
Adenovirus-mediated expression of myogenic differentiation factor 1 (MyoD) in equine and human dermal fibroblasts enables their conversion to caffeine-sensitive myotubes. 2014
Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth. 2013
Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC) 2012
DIFFERENCES BETWEEN METHODOLOGICAL APPROACHES AND ANIMAL SPECIES ON THE WHOLE LIVER DESCELLULARIZATION PROCESS FOR TISSUE ENGINEERING. 2012
NOVEL STRATEGY ON ADENOVIRAL INFECTION OF MESENCHYMAL STEM CELLS FOR IN VITRO AND IN VIVO PURPOSES. 2012
DIFFERENCES IN THE MIGRATORY ABILITY OF MESENCHYMAL STEM CELLS AND iPS TOWARDS TUMOURS 2012
SIMULTANEOUS TRACKING OF MESENCHYMAL STEM CELLS ON DIFFERENT PATHOLOGIES BY NON-INVASIVE IMAGING TECHNIQUES 2012
USE OF GOLD NANOPARTICLES TO ENHANCE THE MSCS ADENOVIRAL INFECTION FOR CELL THERAPIES. 2012
Using living cells to transport therapeutic genes for cancer treatment 2011
Telomerase-driven Expression of the Sodium Iodide Symporter (NIS) for In vivo Radioiodide Treatment of Cancer: A New Broad-spectrum NIS-mediated Antitumor Approach. 2011
Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours 2010

Páginas